Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 22203055)

1.

Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome.

Ramos MV, Auvynet C, Poupel L, Rodero M, Mejias MP, Panek CA, Vanzulli S, Combadiere C, Palermo M.

Am J Pathol. 2012 Mar;180(3):1040-8. doi: 10.1016/j.ajpath.2011.11.011. Epub 2011 Dec 25.

2.

Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.

Ray PE, Liu XH.

Pediatr Nephrol. 2001 Oct;16(10):823-39. Review.

PMID:
11605791
3.

Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome.

Exeni RA, Fernández GC, Palermo MS.

ScientificWorldJournal. 2007 Aug 10;7:1155-64. Review.

4.

[Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome].

Ito K, Hattori M, Matsumoto N.

Nihon Rinsho. 2002 Jun;60(6):1126-30. Review. Japanese.

PMID:
12078084
5.

[Hemolytic uremic syndrome].

Rota S, Cravedi P, Remuzzi G, Ruggenenti P.

G Ital Nefrol. 2005 Nov-Dec;22 Suppl 33:S57-64. Review. Italian.

PMID:
16419008
6.

Escherichia coli Shiga toxin.

Nakao H, Takeda T.

J Nat Toxins. 2000 Aug;9(3):299-313. Review.

PMID:
10994531
7.

Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Zoja C, Buelli S, Morigi M.

Pediatr Nephrol. 2010 Nov;25(11):2231-40. doi: 10.1007/s00467-010-1522-1. Epub 2010 Apr 28. Review.

PMID:
20424866
8.

[Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].

Ibarra C, Goldstein J, Silberstein C, Zotta E, Belardo M, Repetto HA.

Arch Argent Pediatr. 2008 Oct;106(5):435-42. doi: 10.1590/S0325-00752008000500011. Review. Spanish.

9.

Is immune cell activation the missing link in the pathogenesis of post-diarrhoeal HUS?

Heyderman RS, Soriani M, Hirst TR.

Trends Microbiol. 2001 Jun;9(6):262-6. Review.

PMID:
11390240
10.

Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation.

Blackall DP, Marques MB.

Am J Clin Pathol. 2004 Jun;121 Suppl:S81-8. Review.

PMID:
15298153
11.

New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.

Karch H, Friedrich AW, Gerber A, Zimmerhackl LB, Schmidt MA, Bielaszewska M.

Semin Thromb Hemost. 2006 Mar;32(2):105-12. Review.

PMID:
16575685
12.

[Hemolytic uremic syndrome].

Mele C, Noris M.

G Ital Nefrol. 2007 Jan-Feb;24(1):23-33. Review. Italian.

PMID:
17342690
13.

Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Kaplan BS, Cleary TG, Obrig TG.

Pediatr Nephrol. 1990 May;4(3):276-83. Review.

PMID:
2205273
14.

Complement in typical hemolytic uremic syndrome.

Orth D, Würzner R.

Semin Thromb Hemost. 2010 Sep;36(6):620-4. doi: 10.1055/s-0030-1262883. Epub 2010 Sep 23. Review.

PMID:
20865638
15.

Clinical practice. Today's understanding of the haemolytic uraemic syndrome.

Scheiring J, Rosales A, Zimmerhackl LB.

Eur J Pediatr. 2010 Jan;169(1):7-13. doi: 10.1007/s00431-009-1039-4. Epub 2009 Aug 26. Review.

PMID:
19707787
16.

[Primary tubular impairment by verocytotoxin in hemolytic uremic syndrome].

Uchida H, Fujimoto J, Takeda T.

Nihon Rinsho. 1997 Mar;55(3):726-30. Review. Japanese.

PMID:
9086788
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk